SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nasimudeen R. Jabir, Chelapram K. Firoz, Saleh S. Baeesa, Ghulam Md Ashraf, Suhail Akhtar, Warda Kamal, Mohammad A. Kamal, Shams Tabrez, Synopsis on the Linkage of Alzheimer's and Parkinson's Disease with Chronic Diseases, CNS Neuroscience & Therapeutics, 2015, 21, 1
  2. 2
    Bijay Aryal, Jin-Koo Lee, Hak Rim Kim, Hyung-Gun Kim, Alteration of Striatal Tetrahydrobiopterin in Iron-Induced Unilateral Model of Parkinson's Disease, The Korean Journal of Physiology & Pharmacology, 2014, 18, 2, 129

    CrossRef

  3. 3
    Siamak Afshin-Majd, Mohsen Khalili, Mehrdad Roghani, Narges Mehranmehr, Tourandokht Baluchnejadmojarad, Carnosine Exerts Neuroprotective Effect Against 6-Hydroxydopamine Toxicity in Hemiparkinsonian Rat, Molecular Neurobiology, 2014,

    CrossRef

  4. 4
    Govindasamy Pushpavathi Selvakumar, Thamilarasan Manivasagam, Karamkolly R. Rekha, Richard L. Jayaraj, Namasivayam Elangovan, Escin, a Novel Triterpene, Mitigates Chronic MPTP/p-Induced Dopaminergic Toxicity by Attenuating Mitochondrial Dysfunction, Oxidative Stress, and Apoptosis, Journal of Molecular Neuroscience, 2014,

    CrossRef

  5. 5
    Karamkolly R. Rekha, Govindasamy P. Selvakumar, Gene expression regulation of Bcl2, Bax and cytochrome-C by geraniol on chronic MPTP/probenecid induced C57BL/6 mice model of Parkinson’s disease, Chemico-Biological Interactions, 2014, 217, 57

    CrossRef

  6. 6
    Leila Elyasi, Seyed Hassan Eftekhar-Vaghefi, Saeed Esmaeili-Mahani, Morphine Protects SH-SY5Y Human Neuroblastoma Cells Against 6-Hydroxydopamine–Induced Cell Damage: Involvement of Anti-Oxidant, Calcium Blocking, and Anti-Apoptotic Properties, Rejuvenation Research, 2014, 17, 3, 255

    CrossRef

  7. 7
    Fabiana Morroni, Giulia Sita, Andrea Tarozzi, Giorgio Cantelli-Forti, Patrizia Hrelia, Neuroprotection by 6-(methylsulfinyl)hexyl isothiocyanate in a 6-hydroxydopamine mouse model of Parkinson׳s disease, Brain Research, 2014, 1589, 93

    CrossRef

  8. 8
    Guanghui Zhu, Ganping Chen, Lu Shi, Jenny Feng, Yan Wang, Chaohui Ye, Wenke Feng, Jianlou Niu, Zhifeng Huang, PEGylated rhFGF-2 Conveys Long-term Neuroprotection and Improves Neuronal Function in a Rat Model of Parkinson’s Disease, Molecular Neurobiology, 2014,

    CrossRef

  9. 9
    Oytun Erbaş, Bilge Piri Çınar, Volkan Solmaz, Türker Çavuşoğlu, Utku Ateş, The neuroprotective effect of erythropoietin on experimental Parkinson model in rats, Neuropeptides, 2014,

    CrossRef

  10. 10
    Clare Finlay, Susan Duty, Therapeutic potential of targeting glutamate receptors in Parkinson’s disease, Journal of Neural Transmission, 2014, 121, 8, 861

    CrossRef

  11. 11
    Noha F. Abdelkader, Marwa M. Safar, Hesham A. Salem, Ursodeoxycholic Acid Ameliorates Apoptotic Cascade in the Rotenone Model of Parkinson’s Disease: Modulation of Mitochondrial Perturbations, Molecular Neurobiology, 2014,

    CrossRef

  12. 12
    Yong Wang, Xuan Wang, Ran Li, Zhao-Fei Yang, Yi-Zheng Wang, Xiao-Li Gong, Xiao-Min Wang, A DNA Methyltransferase Inhibitor, 5-Aza-2′-Deoxycytidine, Exacerbates Neurotoxicity and Upregulates Parkinson's Disease-Related Genes in Dopaminergic Neurons, CNS Neuroscience & Therapeutics, 2013, 19, 3
  13. 13
    H.L. Gao, C. Li, H. Nabeka, T. Shimokawa, S. Saito, Z.Y. Wang, Y.M. Cao, S. Matsuda, Attenuation of MPTP/MPP+ toxicity in vivo and in vitro by an 18-mer peptide derived from prosaposin, Neuroscience, 2013, 236, 373

    CrossRef

  14. 14
    Pankaj A. Agarwal, A. Jon Stoessl, Biomarkers for trials of neuroprotection in Parkinson's disease, Movement Disorders, 2013, 28, 1
  15. 15
    M.D.A. Teixeira, C.M. Souza, A.P.F. Menezes, M.R.S. Carmo, A.A. Fonteles, J.P. Gurgel, F.A.V. Lima, G.S.B. Viana, G.M. Andrade, Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats, Pharmacology Biochemistry and Behavior, 2013, 110, 1

    CrossRef

  16. 16
    Claudia Funke, Susanne A. Schneider, Daniela Berg, Douglas B. Kell, Genetics and iron in the systems biology of Parkinson’s disease and some related disorders, Neurochemistry International, 2013, 62, 5, 637

    CrossRef

  17. 17
    Hamzeh Pasban-Aliabadi, Saeed Esmaeili-Mahani, Vahid Sheibani, Mehdi Abbasnejad, Anahita Mehdizadeh, Mohammad Mehdi Yaghoobi, Inhibition of 6-Hydroxydopamine-Induced PC12 Cell Apoptosis by Olive (Olea europaeaL.) Leaf Extract Is Performed by Its Main Component Oleuropein, Rejuvenation Research, 2013, 16, 2, 134

    CrossRef

  18. 18
    Kiyoka Kinugawa, Yann Monnet, Lixia Lu, Amaury J. Bekaert, Clotilde Théry, Ziad Mallat, Etienne C. Hirsch, Stéphane Hunot, MFGE8 does not orchestrate clearance of apoptotic neurons in a mouse model of Parkinson's disease, Neurobiology of Disease, 2013, 51, 192

    CrossRef

  19. 19
    Saeed Esmaeili-Mahani, Somayeh Vazifekhah, Hamzeh Pasban-Aliabadi, Mehdi Abbasnejad, Vahid Sheibani, Protective effect of orexin-A on 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells, Neurochemistry International, 2013, 63, 8, 719

    CrossRef

  20. 20
    Makoto Naoi, Wakako Maruyama, Keiko Inaba-Hasegawa, Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms, Expert Review of Neurotherapeutics, 2013, 13, 6, 671

    CrossRef

  21. 21
    Hyo Jin Son, Ji Ae Lee, Nari Shin, Ji Hyun Choi, Jai Woong Seo, Dae Yoon Chi, Cheol Soon Lee, Eun-Mee Kim, Han Choe, Onyou Hwang, A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP, British Journal of Pharmacology, 2012, 165, 7
  22. 22
    Matthew J. Hart, Marcie Glicksman, Min Liu, Mohit K. Sharma, Greg Cuny, Veronica Galvan, Development of a high-throughput screen targeting caspase-8-mediated cleavage of the amyloid precursor protein, Analytical Biochemistry, 2012, 421, 2, 467

    CrossRef

  23. 23
    Min-Jeong Lee, Kai Wang, In-San Kim, Byung-Heon Lee, Hyung Soo Han, Molecular Imaging of Cell Death in an Experimental Model of Parkinson’s Disease with a Novel Apoptosis-Targeting Peptide, Molecular Imaging and Biology, 2012, 14, 2, 147

    CrossRef

  24. 24
    Wu-Fu Chen, Chiranjib Chakraborty, Chun-Sung Sung, Chien-Wei Feng, Yen-Hsuan Jean, Yen-You Lin, Han-Chun Hung, Tzu-Yi Huang, Shi-Ying Huang, Thung-Ming Su, Ping-Jyun Sung, Jyh-Horng Sheu, Zhi-Hong Wen, Neuroprotection by marine-derived compound, 11-dehydrosinulariolide, in an in vitro Parkinson’s model: a promising candidate for the treatment of Parkinson’s disease, Naunyn-Schmiedeberg's Archives of Pharmacology, 2012, 385, 3, 265

    CrossRef

  25. 25
    Susan Duty, Targeting Glutamate Receptors to Tackle the Pathogenesis, Clinical Symptoms and Levodopa-Induced Dyskinesia Associated with Parkinson’s Disease, CNS Drugs, 2012, 26, 12, 1017

    CrossRef

  26. 26
    Giselle Petzinger, Michael Jakowec, Parkinson's Disease, Second Edition, 2012,

    CrossRef

  27. 27
    Kevin McNaught, C Olanow, Parkinson's Disease, Second Edition, 2012,

    CrossRef

  28. 28
    Posung Jeon, Sungjun Yang, Hojoong Jeong, Hyun Kim, Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction, Anatomy & Cell Biology, 2011, 44, 2, 135

    CrossRef

  29. 29
    Silvia Tapia-González, Rosa M Giráldez-Pérez, M Isabel Cuartero, M José Casarejos, M Ángeles Mena, Xiao-Fan Wang, Amelia Sánchez-Capelo, Dopamine and α-synuclein dysfunction in Smad3 null mice, Molecular Neurodegeneration, 2011, 6, 1, 72

    CrossRef

  30. 30
    E.N. Mangano, S. Peters, D. Litteljohn, R. So, C. Bethune, J. Bobyn, M. Clarke, S. Hayley, Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson's disease, Neurobiology of Disease, 2011, 43, 1, 99

    CrossRef

  31. 31
    Naveen Kumar Singhal, Garima Srivastava, Devendra Kumar Patel, Swatantra Kumar Jain, Mahendra Pratap Singh, Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson’s disease phenotype in the mouse, Journal of Pineal Research, 2011, 50, 2
  32. 32
    Inês Pimenta de Castro, L. Miguel Martins, Samantha Hui Yong Loh, Mitochondrial Quality Control and Parkinson’s Disease: A Pathway Unfolds, Molecular Neurobiology, 2011, 43, 2, 80

    CrossRef

  33. 33
    Ailton Melo, Larissa Monteiro, Rute M. F. Lima, Diêgo M. de Oliveira, Martins D. de Cerqueira, Ramon S. El-Bachá, Oxidative Stress in Neurodegenerative Diseases: Mechanisms and Therapeutic Perspectives, Oxidative Medicine and Cellular Longevity, 2011, 2011, 1

    CrossRef

  34. 34
    Rachael A. Dunlop, Ulf T. Brunk, Kenneth J. Rodgers, Proteins containing oxidized amino acids induce apoptosis in human monocytes, Biochemical Journal, 2011, 435, 1, 207

    CrossRef

  35. 35
    Hironori Yokoyama, Hiroto Uchida, Hayato Kuroiwa, Jiro Kasahara, Tsutomu Araki, Role of glial cells in neurotoxin-induced animal models of Parkinson’s disease, Neurological Sciences, 2011, 32, 1, 1

    CrossRef

  36. 36
    Dayane Pessoa De Araújo, Rodrigo De Freitas Guimarães Lobato, José Rodolfo Lopes De Paiva Cavalcanti, Luis Rafael Leite Sampaio, Paulo Victor Pontes Araújo, Marcia Calheiros Chaves Silva, Kelly Rose Tavares Neves, Marta Maria De França Fonteles, Francisca Clea Florenço De Sousa, Silvania Maria Mendes Vasconcelos, The Contributions Of Antioxidant Activity Of Lipoic Acid In Reducing Neurogenerative Progression Of Parkinson’s Disease: A Review, International Journal of Neuroscience, 2011, 121, 2, 51

    CrossRef

  37. 37
    Màtil Calopa, Jordi Bas, Antonio Callén, Mariona Mestre, Apoptosis of peripheral blood lymphocytes in Parkinson patients, Neurobiology of Disease, 2010, 38, 1, 1

    CrossRef

  38. 38
    M. Klinkenberg, N. Thurow, S. Gispert, F. Ricciardi, F. Eich, J.H.M. Prehn, G. Auburger, D. Kögel, Enhanced vulnerability of PARK6 patient skin fibroblasts to apoptosis induced by proteasomal stress, Neuroscience, 2010, 166, 2, 422

    CrossRef

  39. 39
    D. Yang, C.-E. Wang, B. Zhao, W. Li, Z. Ouyang, Z. Liu, H. Yang, P. Fan, A. O'Neill, W. Gu, H. Yi, S. Li, L. Lai, X.-J. Li, Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs, Human Molecular Genetics, 2010, 19, 20, 3983

    CrossRef

  40. 40
    Peng Liu, Xiaoying Wang, Ning Gao, Hua Zhu, Xiaowei Dai, Yanfeng Xu, Chunmei Ma, Lan Huang, Yali Liu, Chuan Qin, G protein-coupled receptor kinase 5, overexpressed in the α-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression, Brain Research, 2010, 1307, 134

    CrossRef

  41. 41
    F B Lima, C L Bethea, Ovarian Steroids Decrease DNA Fragmentation in the Serotonin Neurons of Non-Injured Rhesus Macaques, Molecular Psychiatry, 2010, 15, 6, 657

    CrossRef

  42. 42
    Xiaobing Li, Yan Li, Jianzong Chen, Jing Sun, Xiaofeng Li, Xin Sun, Xiaogang Kang, Tetrahydroxystilbene glucoside attenuates MPP+-induced apoptosis in PC12 cells by inhibiting ROS generation and modulating JNK activation, Neuroscience Letters, 2010, 483, 1, 1

    CrossRef

  43. 43
    Renju Kuriakose, A. Jon Stoessl, Recent Advances in Parkinson’S Disease - Translational and Clinical Research, 2010,

    CrossRef

  44. 44
    Pablo Garrido-Gil, Silvia Belzunegui, Waldy San Sebastián, Amaya Izal-Azcárate, Berta López, Irene Marcilla, Maria Rosario Luquin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys, Journal of Neuroscience Research, 2009, 87, 2
  45. 45
    Phil Hyu Lee, Hyun Jung Park, Bone Marrow-Derived Mesenchymal Stem Cell Therapy as a Candidate Disease-Modifying Strategy in Parkinson's Disease and Multiple System Atrophy, Journal of Clinical Neurology, 2009, 5, 1, 1

    CrossRef

  46. 46
    Makoto Naoi, Wakako Maruyama, Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson’s disease, Expert Review of Neurotherapeutics, 2009, 9, 8, 1233

    CrossRef

  47. 47
    F. Simunovic, M. Yi, Y. Wang, L. Macey, L. T. Brown, A. M. Krichevsky, S. L. Andersen, R. M. Stephens, F. M. Benes, K. C. Sonntag, Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology, Brain, 2009, 132, 7, 1795

    CrossRef

  48. 48
    Yong Wang, Xuan Wang, Limin Liu, Xiaomin Wang, HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells, Neuroscience Letters, 2009, 467, 3, 212

    CrossRef

  49. 49
    R. Nandhagopal, L. Kuramoto, M. Schulzer, E. Mak, J. Cragg, C. S. Lee, J. McKenzie, S. McCormick, A. Samii, A. Troiano, T. J. Ruth, V. Sossi, R. de la Fuente-Fernandez, D. B. Calne, A. J. Stoessl, Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study, Brain, 2009, 132, 11, 2970

    CrossRef

  50. 50
    Cynthia L. Bethea, Arubala P. Reddy, Yukari Tokuyama, Jessica A. Henderson, Fernanda B. Lima, Protective actions of ovarian hormones in the serotonin system of macaques, Frontiers in Neuroendocrinology, 2009, 30, 2, 212

    CrossRef

  51. 51
    Ju Hee Lim, Sa Suk Kim, Doo Hyun Boo, Haja No, Bok Yun Kang, Eun Mee Kim, Onyou Hwang, Hyun Jin Choi, Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes, Neuroscience Letters, 2009, 451, 3, 185

    CrossRef

  52. 52
    Kurt A. Jellinger, Recent advances in our understanding of neurodegeneration, Journal of Neural Transmission, 2009, 116, 9, 1111

    CrossRef

  53. 53
    Eriko Aoki, Ryohei Yano, Hironori Yokoyama, Hiroyuki Kato, Tsutomu Araki, Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice, Experimental and Molecular Pathology, 2009, 86, 1, 57

    CrossRef

  54. 54
    Yazmín Ramiro-Cortés, Julio Morán, Role of oxidative stress and JNK pathway in apoptotic death induced by potassium deprivation and staurosporine in cerebellar granule neurons, Neurochemistry International, 2009, 55, 7, 581

    CrossRef

  55. 55
    Hatasu Kobayashi, Kiyoshi Fukuhara, Saeko Tada-Oikawa, Yuki Yada, Yusuke Hiraku, Mariko Murata, Shinji Oikawa, The mechanisms of oxidative DNA damage and apoptosis induced by norsalsolinol, an endogenous tetrahydroisoquinoline derivative associated with Parkinson’s disease, Journal of Neurochemistry, 2009, 108, 2
  56. 56
    Joanne Clark, David K. Simon, Transcribe to Survive: Transcriptional Control of Antioxidant Defense Programs for Neuroprotection in Parkinson’s Disease, Antioxidants & Redox Signaling, 2009, 11, 3, 509

    CrossRef

  57. 57
    Kuang-Wen Tseng, Yat-Pang Chau, Mei-Fang Yang, Kuo-Shyan Lu, Chung-Liang Chien, Abnormal cellular translocation of α-internexin in spinal motor neurons of Dystonia musculorum mice, Journal of Comparative Neurology, 2008, 507, 1
  58. 58
    Xuping Li, Yunlan Du, Xiaolan Fan, Dehua Yang, Guangrui Luo, Weidong Le, c-Jun N-Terminal Kinase Mediates Lactacystin-Induced Dopamine Neuron Degeneration, Journal of Neuropathology and Experimental Neurology, 2008, 67, 10, 933

    CrossRef

  59. 59
    Luciana Mosca, Italo Tempera, Eugenio Lendaro, Laura Di Francesco, Maria d'Erme, Characterization of catechol-thioether-induced apoptosis in human SH-SY5Y neuroblastoma cells, Journal of Neuroscience Research, 2008, 86, 4
  60. 60
    Sheng Chen, Xiaojie Zhang, Dehua Yang, Yunlan Du, Liang Li, Xuping Li, Ming Ming, Weidong Le, D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways, FEBS Letters, 2008, 582, 5, 603

    CrossRef

  61. 61
    Ferogh A. Ahmadi, Tom N. Grammatopoulos, Andy M. Poczobutt, Susan M. Jones, Laurence D. Snell, Mita Das, W. Michael Zawada, Dopamine Selectively Sensitizes Dopaminergic Neurons to Rotenone-Induced Apoptosis, Neurochemical Research, 2008, 33, 5, 886

    CrossRef

  62. 62
    V. Bogaerts, J. Theuns, C. Van Broeckhoven, Genetic findings in Parkinson’s disease and translation into treatment: a leading role for mitochondria?, Genes, Brain and Behavior, 2008, 7, 2
  63. 63
    Veerle Bogaerts, Karen Nuytemans, Joke Reumers, Philippe Pals, Sebastiaan Engelborghs, Barbara Pickut, Ellen Corsmit, Karin Peeters, Joost Schymkowitz, Peter Paul De Deyn, Patrick Cras, Frederic Rousseau, Jessie Theuns, Christine Van Broeckhoven, Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease, Human Mutation, 2008, 29, 6
  64. 64
    Gunnar P. H. Dietz, Kerstin V. Stockhausen (née Peters), Birgit Dietz, Björn H. Falkenburger, Paola Valbuena, Felipe Opazo, Paul Lingor, Katrin Meuer, Jochen H. Weishaupt, Jörg B. Schulz, Mathias Bähr, Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigra, Journal of Neurochemistry, 2008, 104, 3
  65. 65
    Hyun Jung Park, Phil Hyu Lee, Oh Young Bang, Gwang Lee, Young Hwan Ahn, Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson’s disease, Journal of Neurochemistry, 2008, 107, 1
  66. 66
    Beate Winner, Edward Rockenstein, D. Chichung Lie, Robert Aigner, Michael Mante, Ulrich Bogdahn, Sebastien Couillard-Despres, Eliezer Masliah, Jürgen Winkler, Mutant α-synuclein exacerbates age-related decrease of neurogenesis, Neurobiology of Aging, 2008, 29, 6, 913

    CrossRef

  67. 67
    Hua-Min Xu, Hong Jiang, Jun Wang, Bing Luo, Jun-Xia Xie, Over-expressed human divalent metal transporter 1 is involved in iron accumulation in MES23.5 cells, Neurochemistry International, 2008, 52, 6, 1044

    CrossRef

  68. 68
    Allison D. Ebert, Hoo Jae Hann, Martha C. Bohn, Progressive degeneration of dopamine neurons in 6-hydroxydopamine rat model of parkinson's disease does not involve activation of caspase-9 and caspase-3, Journal of Neuroscience Research, 2008, 86, 2
  69. 69
    S. Omar Ahmad, Ji-Hyuk Park, Jeffery D. Radel, Beth Levant, Reduced numbers of dopamine neurons in the substantia nigra pars compacta and ventral tegmental area of rats fed an n-3 polyunsaturated fatty acid-deficient diet: A stereological study, Neuroscience Letters, 2008, 438, 3, 303

    CrossRef

  70. 70
    Sarika Singh, Madhu Dikshit, Apoptotic neuronal death in Parkinson's disease: Involvement of nitric oxide, Brain Research Reviews, 2007, 54, 2, 233

    CrossRef

  71. 71
    Ennio Esposito, Vincenzo Di Matteo, Giuseppe Di Giovanni, Death in the substantia nigra: a motor tragedy, Expert Review of Neurotherapeutics, 2007, 7, 6, 677

    CrossRef

  72. 72
    Anthony H.V. Schapira, Future directions in the treatment of Parkinson's disease, Movement Disorders, 2007, 22, S17
  73. 73
    Donald R. Staines, Is Parkinson’s disease an autoimmune disorder of endogenous vasoactive neuropeptides?, Medical Hypotheses, 2007, 69, 6, 1208

    CrossRef

  74. 74
    Karuppagounder S. Saravanan, Kizhakke M. Sindhu, Kochupurackal P. Mohanakumar, Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model, Journal of Pineal Research, 2007, 42, 3
  75. 75
    Zhong-Qin Liang, Yun-Lin Li, Xi-Lin Zhao, Rong Han, Xiao-Xia Wang, Yumei Wang, Thomas N. Chase, M. Catherine Bennett, Zheng-Hong Qin, NF-κB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53, Brain Research, 2007, 1145, 190

    CrossRef

  76. 76
    Makio Mogi, Tomoyoshi Kondo, Yoshikuni Mizuno, Toshiharu Nagatsu, p53 protein, interferon-γ, and NF-κB levels are elevated in the parkinsonian brain, Neuroscience Letters, 2007, 414, 1, 94

    CrossRef

  77. 77
    Sandrine Bretaud, Claire Allen, Phillip W. Ingham, Oliver Bandmann, p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease, Journal of Neurochemistry, 2007, 100, 6
  78. 78
    Sun-Yee Kim, Mi-Yeon Kim, Jung-Soon Mo, Jeen-Woo Park, Hee-Sae Park, SAG protects human neuroblastoma SH-SY5Y cells against 1-methyl-4-phenylpyridinium ion (MPP+)-induced cytotoxicity via the downregulation of ROS generation and JNK signaling, Neuroscience Letters, 2007, 413, 2, 132

    CrossRef

  79. 79
    C. Warren Olanow, The pathogenesis of cell death in Parkinson's disease – 2007, Movement Disorders, 2007, 22, S17
  80. 80
    Lee J. Martin, Transgenic Mice with Human Mutant Genes Causing Parkinson's Disease and Amyotrophic Lateral Sclerosis Provide Common Insight into Mechanisms of Motor Neuron Selective Vulnerability to Degeneration, Reviews in the Neurosciences, 2007, 18, 2

    CrossRef

  81. 81
    Mark Hollier, Toni Whistler, Carolyn Dawson, Suzanne D. Vernon, Two optimized combination assays to examine apoptosis pathways in clinical samples, Cytometry Part A, 2007, 71A, 9
  82. 82
    Kevin St. P. McNaught, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  83. 83
    G. Ali Qureshi, Oxidative Stress and Neurodegenerative Disorders, 2007,

    CrossRef

  84. 84
    Peter C. Waldmeier, Oxidative Stress and Neurodegenerative Disorders, 2007,

    CrossRef

  85. 85
    Kurt A. Jellinger, Oxidative Stress and Neurodegenerative Disorders, 2007,

    CrossRef

  86. 86
    Luciana Mosca, Eugenio Lendaro, Maria d’Erme, Sonia Marcellini, Sonia Moretti, Maria Anna Rosei, 5-S-Cysteinyl-dopamine effect on the human dopaminergic neuroblastoma cell line SH-SY5Y, Neurochemistry International, 2006, 49, 3, 262

    CrossRef

  87. 87
    Mark P. Mattson, Tim Magnus, Ageing and neuronal vulnerability, Nature Reviews Neuroscience, 2006, 7, 4, 278

    CrossRef

  88. 88
    Wenguang Xie, Ningsheng Shao, Xiaochang Ma, Baodong Ling, Yushu Wei, Qinxue Ding, Guang Yang, Nongle Liu, Huixin Wang, Keji Chen, Bacterial endotoxin lipopolysaccharide induces up-regulation of glyceraldehyde-3-phosphate dehydrogenase in rat liver and lungs, Life Sciences, 2006, 79, 19, 1820

    CrossRef

  89. 89
    Armando P. Signore, Zhongfang Weng, Teresa Hastings, Amber D. Van Laar, Qinghua Liang, Yong J. Lee, Jun Chen, Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death, Journal of Neurochemistry, 2006, 96, 2
  90. 90
    Patrick M. Abou-Sleiman, Miratul M. K. Muqit, Nicholas W. Wood, Expanding insights of mitochondrial dysfunction in Parkinson's disease, Nature Reviews Neuroscience, 2006, 7, 3, 207

    CrossRef

  91. 91
    Aarne Fleischer, Ata Ghadiri, Frédéric Dessauge, Marianne Duhamel, Maria Paz Rebollo, Fernando Alvarez-Franco, Angelita Rebollo, Modulating apoptosis as a target for effective therapy, Molecular Immunology, 2006, 43, 8, 1065

    CrossRef

  92. 92
    Zhili Huang, Qingsong Hou, Nam Sang Cheung, Qiu-Tian Li, Neuronal cell death caused by inhibition of intracellular cholesterol trafficking is caspase dependent and associated with activation of the mitochondrial apoptosis pathway, Journal of Neurochemistry, 2006, 97, 1
  93. 93
    Mark P. Mattson, Neuronal Life-and-Death Signaling, Apoptosis, and Neurodegenerative Disorders, Antioxidants & Redox Signaling, 2006, 8, 11-12, 1997

    CrossRef

  94. You have free access to this content94
    Paola Piccini, David J. Brooks, New developments of brain imaging for Parkinson's disease and related disorders, Movement Disorders, 2006, 21, 12
  95. 95
    Gülgün Tezel, Oxidative stress in glaucomatous neurodegeneration: Mechanisms and consequences, Progress in Retinal and Eye Research, 2006, 25, 5, 490

    CrossRef

  96. 96
    Massimiliano Di Filippo, Barbara Picconi, Cinzia Costa, Vincenza Bagetta, Michela Tantucci, Lucilla Parnetti, Paolo Calabresi, Pathways of neurodegeneration and experimental models of basal ganglia disorders: Downstream effects of mitochondrial inhibition, European Journal of Pharmacology, 2006, 545, 1, 65

    CrossRef

  97. 97
    Kevin St. P. McNaught, C. Warren Olanow, Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease, Neurobiology of Aging, 2006, 27, 4, 530

    CrossRef

  98. 98
    Hyun Jin Choi, So Yeon Lee, Yuri Cho, Haja No, Seong Who Kim, Onyou Hwang, Tetrahydrobiopterin causes mitochondrial dysfunction in dopaminergic cells: Implications for Parkinson's disease, Neurochemistry International, 2006, 48, 4, 255

    CrossRef

  99. 99
    C. Warren Olanow, Kevin St. P. McNaught, Ubiquitin–proteasome system and Parkinson's disease, Movement Disorders, 2006, 21, 11
  100. 100
    Patricia A. Lawlor, Gene Therapy of the Central Nervous System, 2006,

    CrossRef

  101. 101
    Elizabeth J. Ryu, James M. Angelastro, Lloyd A. Greene, Analysis of gene expression changes in a cellular model of Parkinson disease, Neurobiology of Disease, 2005, 18, 1, 54

    CrossRef

  102. 102
    Wenxue Li, Michael K. Lee, Antiapoptotic property of human α-synuclein in neuronal cell lines is associated with the inhibition of caspase-3 but not caspase-9 activity, Journal of Neurochemistry, 2005, 93, 6
  103. 103
    Enrique Alvarez, Wenbo Zhou, Samir E. Witta, Curt R. Freed, Characterization of the Bex gene family in humans, mice, and rats, Gene, 2005, 357, 1, 18

    CrossRef

  104. 104
    Anumantha G. Kanthasamy, Masashi Kitazawa, Arthi Kanthasamy, Vellareddy Anantharam, Dieldrin-Induced Neurotoxicity: Relevance to Parkinson's Disease Pathogenesis, NeuroToxicology, 2005, 26, 4, 701

    CrossRef

  105. 105
    Angela K. Zimmermann, F. Alexandra Loucks, Shoshona S. Le, Brent D. Butts, Maria L. Florez-McClure, Ron J. Bouchard, Kim A. Heidenreich, Daniel A. Linseman, Distinct mechanisms of neuronal apoptosis are triggered by antagonism of Bcl-2/Bcl-x(L) versus induction of the BH3-only protein Bim, Journal of Neurochemistry, 2005, 94, 1
  106. 106
    José C. Vis, Ellis Schipper, Roelie T. de Boer-van Huizen, Marcel M. Verbeek, Rob M. W. de Waal, Pieter Wesseling, Hans J. ten Donkelaar, Berry Kremer, Expression pattern of apoptosis-related markers in Huntington’s disease, Acta Neuropathologica, 2005, 109, 3, 321

    CrossRef

  107. 107
    H. Behbahani, A. Rickle, H. Concha, M. Ankarcrona, B. Winblad, R.F. Cowburn, Flow cytometry as a method for studying effects of stressors on primary rat neurons, Journal of Neuroscience Research, 2005, 82, 3
  108. 108
    Maher A. Noureddine, Yi-Ju Li, Joelle M. van der Walt, Robert Walters, Rita M. Jewett, Hong Xu, Tianyuan Wang, Jeffrey W. Walter, Burton L. Scott, Christine Hulette, Don Schmechel, Judith E. Stenger, Fred Dietrich, Jeffery M. Vance, Michael A. Hauser, Genomic convergence to identify candidate genes for Parkinson disease: SAGE analysis of the substantia nigra, Movement Disorders, 2005, 20, 10
  109. 109
    Guo-Hua Fan, Chen Qi, Sheng-Di Chen, Heat shock proteins reduce toxicity of 1-methyl-4-phenylpyridinium ion in SK-N-SH cells, Journal of Neuroscience Research, 2005, 82, 4
  110. 110
    Demetrius M. Maraganore, Mariza de Andrade, Timothy G. Lesnick, Kari J. Strain, Matthew J. Farrer, Walter A. Rocca, P.V. Krishna Pant, Kelly A. Frazer, David R. Cox, Dennis G. Ballinger, High-Resolution Whole-Genome Association Study of Parkinson Disease, The American Journal of Human Genetics, 2005, 77, 5, 685

    CrossRef

  111. 111
    Shoshona S. Le, F. Alexandra Loucks, Hiroshi Udo, Sarah Richardson-Burns, Reid A. Phelps, Ron J. Bouchard, Holger Barth, Klaus Aktories, Kenneth L. Tyler, Eric R. Kandel, Kim A. Heidenreich, Daniel A. Linseman, Inhibition of Rac GTPase triggers a c-Jun- and Bim-dependent mitochondrial apoptotic cascade in cerebellar granule neurons, Journal of Neurochemistry, 2005, 94, 4
  112. 112
    Mi-Hyeon Jang, Sae-Bin Jung, Myoung-Hwa Lee, Chang-Ju Kim, Young-Taek Oh, Insug Kang, Jeongseon Kim, Ee-Hwa Kim, Melatonin attenuates amyloid beta25–35-induced apoptosis in mouse microglial BV2 cells, Neuroscience Letters, 2005, 380, 1-2, 26

    CrossRef

  113. 113
    Rieko Kodama, Tomoyoshi Kondo, Hideyuki Yokote, Xuefeng Jing, Takahiro Sawada, Masaya Hironishi, Kazushige Sakaguchi, Nuclear localization of glyceraldehyde-3-phosphate dehydrogenase is not involved in the initiation of apoptosis induced by 1-Methyl-4-phenyl-pyridium iodide (MPP+), Genes to Cells, 2005, 10, 12
  114. 114
    Johannes Everse, Penelope W. Coates, Role of peroxidases in Parkinson disease: a hypothesis, Free Radical Biology and Medicine, 2005, 38, 10, 1296

    CrossRef

  115. 115
    Ravi Shankar Akundi, Eduardo Candelario-Jalil, Sandra Hess, Michael Hüll, Klaus Lieb, Peter J. Gebicke-Haerter, Bernd L. Fiebich, Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia, Glia, 2005, 51, 3
  116. 116
    M. Castiglione, P. Spinsanti, L. Iacovelli, L. Lenti, F. Martini, R. Gradini, V. Di Giorgi Gerevini, A. Caricasole, A. Caruso, R. De Maria, F. Nicoletti, D. Melchiorri, Activation of Fas receptor is required for the increased formation of the disialoganglioside GD3 in cultured cerebellar granule cells committed to apoptotic death, Neuroscience, 2004, 126, 4, 889

    CrossRef

  117. 117
    Eun-Hye Hur, Wonhee Hur, Ju-Youn Choi, In-Kyung Kim, Ho-Youn Kim, Seung Kew Yoon, Hyangshuk Rhim, Functional identification of the pro-apoptotic effector domain in human Sox4, Biochemical and Biophysical Research Communications, 2004, 325, 1, 59

    CrossRef

  118. 118
    O.von Bohlen und Halbach, A Schober, K Krieglstein, Genes, proteins, and neurotoxins involved in Parkinson’s disease, Progress in Neurobiology, 2004, 73, 3, 151

    CrossRef

  119. 119
    Alexandra Zourlidou, Martin D. Payne Smith, David S. Latchman, HSP27 but not HSP70 has a potent protective effect against α-synuclein-induced cell death in mammalian neuronal cells, Journal of Neurochemistry, 2004, 88, 6
  120. 120
    Peter C Waldmeier, William G Tatton, Interrupting apoptosis in neurodegenerative disease: potential for effective therapy?, Drug Discovery Today, 2004, 9, 5, 210

    CrossRef

  121. 121
    François Rannou, Tzong-Shyuan Lee, Rui-Hai Zhou, Jennie Chin, Jeffrey C. Lotz, Marie-Anne Mayoux-Benhamou, Jacques Patrick Barbet, Alain Chevrot, John Y.-J. Shyy, Intervertebral Disc Degeneration, The American Journal of Pathology, 2004, 164, 3, 915

    CrossRef

  122. 122
    Isabel Liste, Beatriz Navarro, Jens Johansen, Carlos Bueno, Ana Villa, Teit E. Johansen, Alberto Martínez-Serrano, Low-Level Tyrosine Hydroxylase (TH) Expression Allows for the Generation of Stable TH+Cell Lines of Human Neural Stem Cells, Human Gene Therapy, 2004, 15, 1, 13

    CrossRef

  123. 123
    Takao Yasuhara, Tetsuro Shingo, Kazuki Kobayashi, Akira Takeuchi, Akimasa Yano, Kenichiro Muraoka, Toshihiro Matsui, Yasuyuki Miyoshi, Hirofumi Hamada, Isao Date, Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease, European Journal of Neuroscience, 2004, 19, 6
  124. 124
    Paolo Bonini, Simona Cicconi, Alessio Cardinale, Cristiana Vitale, Anna Lucia Serafino, Maria Teresa Ciotti, Lionel N.J-L. Marlier, Oxidative stress induces p53-mediated apoptosis in glia: p53 transcription-independent way to die, Journal of Neuroscience Research, 2004, 75, 1
  125. 125
    Mei Gu, M. Irvani, J Mark Cooper, Diane King, Peter Jenner, Anthony H. V. Schapira, Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms, Journal of Neurochemistry, 2004, 91, 5
  126. 126
    J.M.B. Wilson, M.S. Petrik, S.C. Grant, S.J. Blackband, J. Lai, C.A. Shaw, Quantitative measurement of neurodegeneration in an ALS–PDC model using MR microscopy, NeuroImage, 2004, 23, 1, 336

    CrossRef

  127. 127
    Francisco J. Diaz-Corrales, Masato Asanuma, Ikuko Miyazaki, Norio Ogawa, Rotenone induces disassembly of the Golgi apparatus in the rat dopaminergic neuroblastoma B65 cell line, Neuroscience Letters, 2004, 354, 1, 59

    CrossRef

  128. 128
    Martin V. Pedersen, Lene B. Køhler, Mariam Grigorian, Vera Novitskaya, Elisabeth Bock, Eugine Lukanidin, Vladimir Berezin, The Mts1/S100A4 protein is a neuroprotectant, Journal of Neuroscience Research, 2004, 77, 6
  129. 129
    T. Yasuhara, T. Shingo, I. Date, The Potential Role of Vascular Endothelial Growth Factor in the Central Nervous System, Reviews in the Neurosciences, 2004, 15, 4

    CrossRef

  130. 130
    Judith M. Horowitz, Danielle M. Pastor, Alpna Goyal, Subrata Kar, Navindra Ramdeen, Brian H. Hallas, German Torres, BAX protein-immunoreactivity in midbrain neurons of Parkinson’s disease patients, Brain Research Bulletin, 2003, 62, 1, 55

    CrossRef

  131. 131
    Shun Shimohama, Hideyuki Sawada, Yoshihisa Kitamura, Takashi Taniguchi, Disease model: Parkinson's disease, Trends in Molecular Medicine, 2003, 9, 8, 360

    CrossRef

  132. 132
    Saeko Tada-Oikawa, Yusuke Hiraku, Michiko Kawanishi, Shosuke Kawanishi, Mechanism for generation of hydrogen peroxide and change of mitochondrial membrane potential during rotenone-induced apoptosis, Life Sciences, 2003, 73, 25, 3277

    CrossRef

  133. 133
    Anthony H. V. Schapira, C. Warren Olanow, Rationale for the use of dopamine agonists as neuroprotective agents in Parkinson's disease, Annals of Neurology, 2003, 53, S3
  134. 134
    Parkinson's Disease, Wiley Handbook of Current and Emerging Drug Therapies,